Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shehuang is a topical Traditional Chinese Medicine (TCM) formulation developed by Chengdu Huasen Pharmaceutical High-Tech for the treatment of chronic eczema. The preparation, often referred to as Shehuang Cream or Shehuang Rugao, typically incorporates active components such as artificial musk and sulfur, which are recognized in traditional medicine for their anti-inflammatory, antipruritic, and antiseptic properties. It has been investigated in Phase II clinical trials in China (e.g., CTR20132696) to evaluate its efficacy and safety profile compared to placebo in patients suffering from chronic eczema.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shehuang.